ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Eli Lilly (LLY) Technical (Analysis) Reports Eli Lilly ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Eli Lilly (LLY)

Technical Analysis Report for NYSE stock LLY Eli Lilly. Dated: 14 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NYSE stock LLY Eli Lilly then click here. or read Experts views on Eli Lilly or Forecast & share price targets of Eli Lilly

Eli Lilly Opened at 1080.18 and Closed at: 1073.81, which is -0.31% of previous session's close. It moved within a range of 1061.12 and 1084.00
The session was a Bearish session with an average volume of 957755, which is -129.08% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

Support for tomorrow is 1056.03 and resistance for tomorrow is 1078.91
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1061.95, 1050.1 resistance for tomorrow's hourly charts is 1084.83, 1095.86

10 Day SMA for Eli Lilly (LLY) is 1074.9 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Eli Lilly (LLY) is 1071.68 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Eli Lilly (LLY) is 1036.17 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 904.46 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Eli Lilly is 835.08 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Eli Lilly is at 1071.68 and 200 DMA is at 835.08, while 50 DMA and 100 DMA are at 1036.17 and 904.46 respectively

Eli Lilly (LLY) moving average of 20 SMA is at 1071.68 and 20 EMA is at 1066.44

Eli Lilly (LLY) moving average of 50 SMA is at 1036.17 and 50 EMA is at 1018.01

Eli Lilly (LLY) moving average of 100 SMA is at 904.46 and 100 EMA is at 947.21

Eli Lilly (LLY) moving average of 200 SMA is at 835.08 and 200 EMA is at 888.67

Eli Lilly has performed better than Universal Health in short term. Holding Eli Lilly could be a better choice for now!

Eli Lilly has performed better than Tenet Healthcare in short term. Holding Eli Lilly could be a better choice for now!

Takeda Pharmaceutical has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 11.5% more returns!

Steris Plc has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Steris Plc, about 2.58% more returns!

Smith Nephew has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Smith Nephew, about 0.04% more returns!

Msa Safety has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Msa Safety, about 11.24% more returns!

Molina Healthcare has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Molina Healthcare, about 15.55% more returns!

Eli Lilly has performed better than Medtronic Plc in short term. Holding Eli Lilly could be a better choice for now!

Eli Lilly has performed better than Mednax Inc in short term. Holding Eli Lilly could be a better choice for now!

Baxter International has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Baxter International, about 2.3% more returns!

Becton Dickinson has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Becton Dickinson, about 3.77% more returns!

Bausch Health has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Bausch Health, about 5.65% more returns!

Eli Lilly has performed better than Cigna Corporation in short term. Holding Eli Lilly could be a better choice for now!

Charles River has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Charles River, about 8.99% more returns!

Eli Lilly has performed better than Davita Inc in short term. Holding Eli Lilly could be a better choice for now!

Globus Medical has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Globus Medical, about 5.92% more returns!

Glaxosmithkline Plc has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 2.27% more returns!

Eli Lilly has performed better than Haemonetics Corporation in short term. Holding Eli Lilly could be a better choice for now!

Johnson Johnson has performed better than Eli Lilly in short term. You could have earned much better returns by investing in Johnson Johnson, about 2.57% more returns!

Eli Lilly Technical analysis of indicators

Price action analysis of Eli Lilly (LLY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Eli Lilly stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Eli Lilly in short term but the sell signal is initial and weak.

Eli Lilly Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Eli Lilly in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Eli Lilly is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1075.57 and Eli Lilly LLY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Eli Lilly LLY stock. Volume based technical analysis of Eli Lilly LLY stock is negative.

Eli Lilly Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NYSE stock LLY Eli Lilly These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And LLY Experts View which covers a lot of information including buying and selling signals

LLY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Eli Lilly or View Candle Stick Charts here

Chart Eli Lilly (LLY)  Technical (Analysis) Reports Eli Lilly [

Videos related to: Eli Lilly (LLY) Technical (Analysis) Reports Eli Lilly ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Eli Lilly (LLY)  Technical (Analysis) Reports Eli Lilly [

 

Back to top